UTILIZATION OF PHYSIOLOGICALLY BASED PHARMACOKINETIC MODEL (PBPK) TO STUDY THE INFLUENCE OF BODY FAT MASS AND INDUCTION OF CYP1A2 ON THE PHARMACOKINETICS OF TCDD Publication Attachment: 03-681.pdf Authors: Emond, C, Birnbaum, LS, DeVito, MJ Year: 2003
